Free Republic

A new experimental nasal spray could prevent people from getting infected with COVID-19 for up to eight hours, according to a study. The promising treatment has shown it can block infection from the virus in lab studies with mice, according to researchers at the University of Helsinki in Finland.

Nathan Jones, CEO of Xlear, said that he feels that his company is emerging from the COVID-19 pandemic in better shape and is prepared to help retailers in the post-COVID era. He talked with Drug Store News about the challenges ahead. Drug Store News: How has Xlear fared during the pandemic? Nathan Jones: Xlear as a company has fared fairly well. It is a respiratory pandemic and, within a month of it starting, we had physicians around the world tell people that using nasal sprays like ours, nasal sprays that contain antiviral agents, would be of benefit to them. There...